Antidepressant-like effects of Salvianolic acid B in the mouse forced swim and tail suspension tests

Life Sciences

Volumn 90, Issue 25-26, 2012, Pages 1010-1014

  Feng, Yi ^a   You, Zili ^a,b   Yan, Shuo ^a   He, Gang ^c   Chen, Yubo ^a   Gou, Xiaojun ^c   Peng, Cheng ^b  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c CHENGDU UNIVERSITY   (China)

Author keywords

Antidepressant; Forced swimming test; Salvia miltiorrhiza; Salvianolic acid B; Tail suspension test

Indexed keywords

IMIPRAMINE; SALVIANOLIC ACID B;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NEUROPROTECTION; NONHUMAN; PLANT ROOT; SALVIA MILTIORRHIZA; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZOFURANS; DEPRESSION; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PLANT ROOTS; SWIMMING; TREATMENT OUTCOME;

MUS; SALVIA MILTIORRHIZA;

EID: 84863318406     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.05.021     Document Type: Article

References (54)

1. D. Abdulla, and K.W. Renton Beta-adrenergic receptor modulation of the LPS-mediated depression in CYP1A activity in astrocytes Biochem Pharmacol 69 2005 741 750
2. D. Baldwin, K. Bridgman, and C. Buis Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine J Psychopharmacol 20 2006 91 96
3. R. Barber Inflammatory signaling in Alzheimer disease and depression Cleve Clin J Med 78 Suppl. 1 2011 S47 S49
4. A.D. Basterzi, C. Aydemir, C. Kisa, S. Aksaray, V. Tuzer, and K. Yazici IL-6 levels decrease with SSRI treatment in patients with major depression Hum Psychopharmacol 20 2005 473 476
5. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat Rev 7 2006 137 151
6. E.S. Brown, F.P. Varghese, and B.S. McEwen Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 55 2004 1 9
7. M.D. Burton, N.L. Sparkman, and R.W. Johnson Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide- induced sickness behavior J Neuroinflammation 8 2011 54
8. F. Caraci, A. Copani, F. Nicoletti, and F. Drago Depression and Alzheimer's disease: neurobiological links and common pharmacological targets Eur J Pharmacol 626 2010 64 71
9. M. Catena-Dell'Osso, C. Bellantuono, G. Consoli, S. Baroni, F. Rotella, and D. Marazziti Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem 18 2011 245 255
10. Y.H. Chen, G.H. Du, and J.T. Zhang Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats Acta Pharmacol Sin 21 2000 463 466
11. T. Chen, W. Liu, X. Chao, L. Zhang, Y. Qu, and J. Huo Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice Brain Res Bull 84 2011 163 168
12. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci Biobehav Rev 29 2005 571 625
13. H. Dang, Y. Chen, X. Liu, Q. Wang, L. Wang, and W. Jia Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1417 1424
14. G.H. Du, Y. Qiu, and J.T. Zhang Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice J Asian Nat Prod Res 2 2000 145 152
15. M. Fava Diagnosis and definition of treatment-resistant depression Biol Psychiatry 53 2003 649 659
16. E. Fuchs, and G. Fliugge Experimental animal models for the simulation of depression and anxiety Dialogues Clin Neurosci 8 2006 323 333
17. J.Y. Guo, C.Y. Li, Y.P. Ruan, M. Sun, X.L. Qi, and B.S. Zhao Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain Eur J Pharmacol 612 2009 54 60
18. R.A. Hansen, G. Gartlehner, K.N. Lohr, B.N. Gaynes, and T.S. Carey Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder Ann Intern Med 143 2005 415 426
19. M. Hattesohl, B. Feistel, H. Sievers, R. Lehnfeld, M. Hegger, and H. Winterhoff Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties Phytomedicine 15 2008 2 15
20. J.H. Ho, and C.Y. Hong Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection J Biomed Sci 18 2011 30
21. J. Hwang, L.T. Zheng, J. Ock, M.G. Lee, S.H. Kim, and H.W. Lee Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants Neuropharmacology 55 2008 826 834
22. R.C. Kessler, W.T. Chiu, O. Demler, K.R. Merikangas, and E.E. Walters Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 2005 617 627
23. S.K. Kulkarni, and A. Dhir Effect of various classes of antidepressants in behavioral paradigms of despair Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1248 1254
24. J.P. Lepine, and M. Briley The increasing burden of depression Neuropsychiatr Dis Treat 7 2011 3 7
25. S.J. Lin, I.T. Lee, Y.H. Chen, F.Y. Lin, L.M. Sheu, and H.H. Ku Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells J Cell Biochem 100 2007 372 384
26. C.S. Liu, Y. Cheng, J.F. Hu, W. Zhang, N.H. Chen, and J.T. Zhang Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761) Acta Pharmacol Sin 27 2006 1137 1145
27. D. Liu, Z. Wang, S. Liu, F. Wang, S. Zhao, and A. Hao Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells Neuropharmacology 61 2011 592 599
28. D.Y. Lu, Y.Y. Tsao, Y.M. Leung, and K.P. Su Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids Neuropsychopharmacology 35 2010 2238 2248
29. I. Lucki, A. Dalvi, and A.J. Mayorga Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology 155 2001 315 322
30. L. Mattioli, C. Funari, and M. Perfumi Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats J Psychopharmacol 23 2009 130 142
31. N.T. McCall, P. Parks, K. Smith, G. Pope, and M. Griggs The prevalence of major depression or dysthymia among aged Medicare Fee-for-Service beneficiaries Int J Geriatr Psychiatry 17 2002 557 565
32. M. Molina-Hernandez, N.P. Tellez-Alcantara, J. Perez-Garcia, J.I. Olivera-Lopez, and M.T. Jaramillo-Jaimes Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1660 1666
33. A. Monji The microglia hypothesis of psychiatric disorders Nihon Shinkei Seishin Yakurigaku Zasshi 31 2011 1 8
34. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
35. T.M. Piser Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants Brain Behav Immun 24 2010 515 524
36. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
37. T.J. Raedler Inflammatory mechanisms in major depressive disorder Curr Opin Psychiatry 24 2011 519 525
38. C.E. Renard, E. Dailly, D.J. David, M. Hascoet, and M. Bourin Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test Fundam Clin Pharmacol 17 2003 449 455
39. S.J. Rizvi, and S.H. Kennedy The keys to improving depression outcomes Eur Neuropsychopharmacol 21 Suppl. 4 2011 S694 S702
40. C. Roumestan, A. Michel, F. Bichon, K. Portet, M. Detoc, and C. Henriquet Anti-inflammatory properties of desipramine and fluoxetine Respir Res 8 2007 35
41. L.E. Schechter, R.H. Ring, C.E. Beyer, Z.A. Hughes, X. Khawaja, and J.E. Malberg Innovative approaches for the development of antidepressant drugs: current and future strategies NeuroRx 2 2005 590 611
42. R. Schulz, R.A. Drayer, and B.L. Rollman Depression as a risk factor for non-suicide mortality in the elderly Biol Psychiatry 52 2002 205 225
43. A. Sluzewska, J.K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann N Y Acad Sci 762 1995 474 476
44. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology 85 1985 367 370
45. M.K. Tang, and J.T. Zhang Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro Acta Pharmacol Sin 22 2001 380 384
46. B.J. Tesch Herbs commonly used by women: an evidence-based review Am J Obstet Gynecol 188 2003 S44 S55
47. Y.P. Tsao, J.Y. Lin, J.T. Jan, C.H. Leng, C.C. Chu, and Y.C. Yang HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins Biochem Biophys Res Commun 344 2006 63 71
48. R.J. Tynan, S. Naicker, M. Hinwood, E. Nalivaiko, K.M. Buller, and D.V. Pow Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions Brain Behav Immun 24 2010 1058 1068
49. S. Umukoro, A.O. Akinyinka, and A.C. Aladeokin Antidepressant activity of methyl jasmonate, a plant stress hormone in mice Pharmacol Biochem Behav 98 2011 8 11
50. S.X. Wang, L.M. Hu, X.M. Gao, H. Guo, and G.W. Fan Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect Neurochem Res 35 2010 1029 1037
51. Y. Xu, S. Li, M.M. Vernon, J. Pan, L. Chen, and P.A. Barish Curcumin prevents corticosterone-induced neurotoxicity and abnormalities of neuroplasticity via 5-HT receptor pathway J Neurochem 118 2011 784 795
52. Z. You, C. Luo, W. Zhang, Y. Chen, J. He, and Q. Zhao Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression Behav Brain Res 225 2011 135 141
53. G. Zeng, T. Tang, H.J. Wu, W.H. You, J.K. Luo, and Y. Lin Salvianolic acid B protects SH-SY5Y neuroblastoma cells from 1-methyl-4-phenylpyridinium- induced apoptosis Biol Pharm Bull 33 2011 1337 1342
54. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J Clin Pharmacol 45 2005 1345 1359